Avid Bioservices (CDMO)
(Delayed Data from NSDQ)
$8.83 USD
-0.17 (-1.89%)
Updated Sep 6, 2024 03:59 PM ET
After-Market: $8.82 -0.01 (-0.11%) 7:58 PM ET
3-Hold of 5 3
D Value D Growth B Momentum D VGM
Price, Consensus and EPS Surprise
CDMO 8.83 -0.17(-1.89%)
Will CDMO be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for CDMO based on the 1-3 month trading system that more than doubles the S&P 500.
About Price, Consensus and EPS Surprise
The Price, Consensus and EPS Surprise chart displays the company's stock price along with the consensus estimate and the EPS surprise. Zacks tracks individual sell-side analyst estimates and creates a consensus EPS estimates. The consensus estimate is the average of all the current estimates made available by brokerage analysts. Consensus estimates are more advantageous because they reduce the risk of any single analyst making an incorrect forecast. ZACKS CONSENSUS ESTIMATE = THE AVERAGE OF ALL CURRENT EPS ESTIMATES. EPS Surprise is the difference (expressed as a percentage) between the actual reported quarterly earnings per share (EPS) vs the estimated quarterly EPS. A company that reports $1.10 in actual quarterly EPS vs. $1.00 in estimated quarterly EPS would show a 10% positive EPS surprise. ((Actual EPS - Estimated EPS) / absolute Estimated EPS) *100 = EPS Surprise %.
Zacks News for CDMO
Avid Bioservices (CDMO) Reports Q2 Loss, Lags Revenue Estimates
Down -22.27% in 4 Weeks, Here's Why Avid Bioservices (CDMO) Looks Ripe for a Turnaround
CDMO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Twist Bioscience (TWST) Reports Q4 Loss, Tops Revenue Estimates
BioCardia (BCDA) Soars 168% on FDA Nod to Heart Failure Study
Avid Bioservices (CDMO) Moves 9.0% Higher: Will This Strength Last?
Other News for CDMO
What To Expect From Avid Bioservices Inc (CDMO) Q1 2025 Earnings
Avid Bioservices (CDMO) Gets a Buy from Craig-Hallum
Avid Bioservices to Report Financial Results for First Quarter of Fiscal Year 2025 After Market Close on September 9, 2024
Earnings week ahead: Zscaler, DocuSign, NIO, Broadcom and more
AMR Update - Mid-2024